The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 15 October 2001. doi:10.1084/jem.194.8.1097
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 923K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castedo, M.
Right arrow Articles by Kroemer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castedo, M.
Right arrow Articles by Kroemer, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-SERINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/10/1097/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 8, October 15, 2001 1097-1110


Original Article

Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-Induced Apoptosis Involves Mammalian Target of Rapamycin/Fkbp12-Rapamycin–Associated Protein–Mediated P53 Phosphorylation

Maria Castedoa, Karine F. Ferria, Julià Blancob, Thomas Roumiera, Nathanael Larochettea, Jordi Barretinab, Alessandra Amendolac, Roberta Nardaccic, Didier Métiviera, José A. Esteb, Mauro Piacentinic,d, and Guido Kroemera

a Centre National de la Recherche Scientifique, UMR1599, Institut Gustave Roussy, F-94805 Villejuif, France
b Institut de Recerca de la SIDA-Caixa, Laboratori de Retrovirologia, Hospital Universitari Germans Trias i Pujol, Universitat Autónoma de Barcelona, 08916 Badalona, Catalonia, Spain
c Istituto Nazionale Malattie Infettive "L. Spallanzani", University of Rome Tor Vergata, Rome 00133, Italy
d Department of Biology, University of Rome Tor Vergata, Rome 00133, Italy
CNRS-UMR1599, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille-Desmoulins, F-94805 Villejuif, France.33-1-4211-604733-1-4211-6046

kroemer{at}igr.fr

Syncytia arising from the fusion of cells expressing a lymphotropic human immunodeficiency virus (HIV)-1–encoded envelope glycoprotein complex (Env) gene with cells expressing the CD4/CXCR4 complex undergo apoptosis through a mitochondrion-controlled pathway initiated by the upregulation of Bax. In syncytial apoptosis, phosphorylation of p53 on serine 15 (p53S15) precedes Bax upregulation, the apoptosis-linked conformational change of Bax, the insertion of Bax in mitochondrial membranes, subsequent release of cytochrome c, caspase activation, and apoptosis. p53S15 phosphorylation also occurs in vivo, in HIV-1+ donors, where it can be detected in preapoptotic and apoptotic syncytia in lymph nodes, as well as in peripheral blood mononuclear cells, correlating with viral load. Syncytium-induced p53S15 phosphorylation is mediated by the upregulation/activation of mammalian target of rapamycin (mTOR), also called FKBP12-rapamycin-associated protein (FRAP), which coimmunoprecipitates with p53. Inhibition of mTOR/FRAP by rapamycin reduces apoptosis in several paradigms of syncytium-dependent death, including in primary CD4+ lymphoblasts infected by HIV-1. Concomitantly, rapamycin inhibits p53S15 phosphorylation, mitochondrial translocation of Bax, loss of the mitochondrial transmembrane potential, mitochondrial release of cytochrome c, and nuclear chromatin condensation. Transfection with dominant negative p53 has a similar antiapoptotic action as rapamycin, upstream of the Bax upregulation/translocation. In summary, we demonstrate that phosphorylation of p53S15 by mTOR/FRAP plays a critical role in syncytial apoptosis driven by HIV-1 Env.

Key Words: cell death • envelope glycoprotein complex • human immunodeficiency virus • mitochondria • rapamycin


M. Castedo and K.F. Ferri contributed equally to this paper.

Abbreviations used in this paper: 4EBP, 4E-binding protein; ATM, ataxia teleangiectasia mutated; ATR, ataxia teleangiectasia Rad3; Cyt. c, cytochrome c; DNA-PK, DNA-dependent protein kinase; Env, envelope glycoprotein complex; FRAP, FKBP12-rapamycin-associated protein; GFP, green fluorescent protein; MEF, mouse embryonic fibroblast; MMP, mitochondrial membrane permeabilization; mTOR, mammalian target of rapamycin; PEG, polyethylene glycol; PIKK, phosphatidylinositol kinase-related kinases; SC, single cell; TOP, terminal oligopyrimidine; tTGase, tissue transglutaminase.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS